HYFT Latest Press Releases

-- October 26, 2026 --

A Personalized Cancer Therapy Delivered Positive Phase 3 Results; The Next Race Is Picking Better Targets Globe Newswire 8:53 AM

-- October 22, 2026 --

MindWalk Holdings Corp. Announces Leadership Update Business Wire 5:00 PM

-- October 21, 2026 --

AI Can Design Antibodies Faster Than Anyone Can Check Them for Immune Risk. That Gap Is Starting to Close. Globe Newswire 10:00 AM

MindWalk Screens 890,634 Antibody Sequences for Immune Risk in Under Five Hours Business Wire 8:01 AM

-- October 14, 2026 --

AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test Globe Newswire 9:45 AM

MindWalk Holdings Corp. Strengthens Boston-Based Development Leadership as Pipeline Advances Toward Preclinical Efficacy Studies Business Wire 8:01 AM

-- October 6, 2026 --

Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context Globe Newswire 9:15 AM

MindWalk (NASDAQ: HYFT): Enterprise AI Has Found Its Ontology Layer. Biology Needs One Grounded in Biological Function Business Wire 8:46 AM

-- October 1, 2026 --

MindWalk Appoints Kim Remizowski to Board of Directors as Independent Director Business Wire 8:46 AM

-- September 22, 2026 --

Chipmakers Now Ship Protein-Folding AI as Plug-and-Play Microservices Globe Newswire 8:30 AM

-- September 21, 2026 --

MindWalk Brings OpenFold3 into Production in Minutes with AMD Inference Microservices on Vultr Kubernetes Engine Business Wire 8:46 AM

-- September 14, 2026 --

MindWalk Reports 21% Revenue Growth and Gross Margin Expansion to 59% in Fiscal First Quarter 2027 Business Wire 4:56 PM

MindWalk Lands Binding Commitment for US$30 Million Unsecured Credit Facility to Fund Biologics Programs and Commercial Expansion Business Wire 8:46 AM

-- September 10, 2026 --

MindWalk to Participate in the H.C. Wainwright 28th Annual Global Investment Conference Business Wire 8:34 AM

-- September 8, 2026 --

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for First Quarter Fiscal Year 2027 on September 14, 2026 Business Wire 8:30 AM

-- September 3, 2026 --

The Market Just Told You Which Layer Of AI Biology It Is Paying For Globe Newswire 2:10 PM

-- August 19, 2026 --

Most AI Drug Discovery Reads the Genetic Code. The Next Wave Is Learning to Read What the Code Actually Does. Globe Newswire 8:56 AM

-- August 10, 2026 --

AI Found an Influenza Target That Survives Viral Mutation Globe Newswire 9:10 AM

-- July 23, 2026 --

MindWalk Showcases ReefIQ for AI Drug Discovery at AMD Advancing AI Business Wire 4:02 PM

-- July 22, 2026 --

MindWalk Holdings Corp. Reports Fiscal 2026 Results: Revenue Up 46% as the Company Completes Its Pivot to Bio-Native AI Infrastructure Business Wire 4:54 PM

-- July 13, 2026 --

MindWalk Holdings Corp. to Report Financial Results and Recent Business Highlights for Fourth Quarter and Full Fiscal Year 2026 on July 22, 2026 Business Wire 9:00 AM

-- July 6, 2026 --

As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models PRNewswire 8:55 AM

MindWalk Holdings Corp. (NASDAQ: HYFT) Added to the Russell 3000E Index, Expanding Institutional Investment Opportunity Business Wire 8:30 AM

-- July 1, 2026 --

As AI Models Become Commodities, One Bio-Native AI Company Just Moved to Patent the Thing That Actually Compounds: the Data PRNewswire 9:01 AM

MindWalk (NASDAQ: HYFT) Files Patent for High-Dimensional Biological Data Architecture Powering AI Drug Discovery Business Wire 8:00 AM

-- June 16, 2026 --

The Quiet Bottleneck in AI Drug Discovery Isn't the Model -- It's the Biology Underneath It PRNewswire 8:45 AM

-- June 12, 2026 --

MindWalk (NASDAQ: HYFT) CEO Dr. Jennifer Bath to Join Absci (NASDAQ: ABSI) and a Leading AI Compute Provider on Jones AI Day Panel on the Future of AI Drug Discovery Business Wire 9:00 AM

-- June 10, 2026 --

MindWalk Holdings Corp. (NASDAQ: HYFT) Launches ReefIQ , a Biological Context Layer for AI Drug Discovery Business Wire 9:16 AM

-- June 2, 2026 --

MindWalk's Preclinical Dengue Data Support a HYFT Computational Prediction: Immunogens Designed on the Predicted Target Elicited Cross-Reactive Antibodies Against Antigens of All Four Dengue Serotypes, Reproduced Across Two Independent Campaigns Business Wire 7:20 AM